Foreword for genetic determinants of pregnancy loss: Mechanisms, diagnostic advances, and clinical implications [0.03%]
遗传决定因素与流产：机制、诊断进展和临床意义导论
Jerrold B Leikin
Jerrold B Leikin
Genetic determinants of pregnancy loss: Mechanisms, diagnostic advances, and clinical implications [0.03%]
妊娠丢失的遗传决定因素：机制、诊断进展和临床意义
Shamsun Nahar,Ahmed Shayer Andalib,Sume Akther et al.
Shamsun Nahar et al.
Background: Pregnancy loss affects up to 15% of clinically recognized pregnancies, posing a major clinical and emotional burden. While chromosomal abnormalities account for most early miscarriages, many previously unexpla...
Rick Kellerman
Rick Kellerman
Disturbances due to cold [0.03%]
冷扰动
Jerrold B Leikin,Scott M Leikin,Frederick K Korley et al.
Jerrold B Leikin et al.
Hypothermia is classically defined as a reduction in the body's core temperature below 95.0°F (35.0 °C). Most reported cases of hypothermia are due to environmental exposure to low ambient temperatures (accidental hypothermia). Other caus...
GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review [0.03%]
GLP-1受体激动剂与中风和帕金森病的神经保护作用：系统综述
Drashti S Parekh,Dastan Kudaiarov,Pugazhendi Inban et al.
Drashti S Parekh et al.
Background: Glucagon-like peptide-1 receptor agonists have been shown to have neuroprotective effects in metabolic diseases, but their application in neurodegenerative diseases (stroke and Parkinson's disease) has not bee...
GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review [0.03%]
肠泌素受体激动剂用于体重管理及其在癌症、糖尿病和心血管病高风险人群中的潜在抗凝血风险作用：系统评价
Rushin S Parekh,Pugazhendi Inban,Andy Thai et al.
Rushin S Parekh et al.
Background: Thromboembolic risk is increased in obesity and cardiometabolic disorders. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) also facilitate weight loss and cardiovascular benefits, yet their effects on thr...
Nathan Richard Fletcher,Michael Yu,Angela Pauline P Calimag-Loyola et al.
Nathan Richard Fletcher et al.
Foreword for Glucagon-like peptide-1 receptor agonists (GLP-1) and its promise for potential benefits [0.03%]
GLP-1受体激动剂及其潜在益处的前言
Jerrold B Leikin
Jerrold B Leikin
Foreword for periodontal disease and diabetic kidney disease: A comprehensive analysis [0.03%]
牙周病与糖尿病肾病：全面分析的前言
Jerrold B Leikin
Jerrold B Leikin